Emanuela Ferraro

2.2k total citations · 1 hit paper
54 papers, 1.3k citations indexed

About

Emanuela Ferraro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Emanuela Ferraro has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Emanuela Ferraro's work include HER2/EGFR in Cancer Research (25 papers), Advanced Breast Cancer Therapies (23 papers) and Breast Cancer Treatment Studies (17 papers). Emanuela Ferraro is often cited by papers focused on HER2/EGFR in Cancer Research (25 papers), Advanced Breast Cancer Therapies (23 papers) and Breast Cancer Treatment Studies (17 papers). Emanuela Ferraro collaborates with scholars based in United States, Italy and Spain. Emanuela Ferraro's co-authors include Giuseppe Curigliano, Stefania Morganti, Paolo Tarantino, Shanu Modi, Joshua Z. Drago, Dario Trapani, Bruno A. Duso, Giulia Viale, Paolo D’Amico and Antonio Marra and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Emanuela Ferraro

45 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HER2-Low Breast Cancer: Pathological and Clinical Landscape

2020 490 citations Paolo Tarantino, Erika Hamilton et al. Journal of Clinical Oncology profile →

Peers

Emanuela Ferraro

ONCOL

PRM

RNMI

Noam Pondé Belgium

Gaia Griguolo Italy

Sònia Pernas Spain

Mythili Shastry United States

Juan Miguel Cejalvo Spain

Ying Fan China

José Jiménez Spain

Zhimin Shao China

Conleth G. Murphy Ireland

Akihiko Shimomura Japan

Noam Pondé Belgium

Emanuela Ferraro

981 ×1.1

ONCOL

488 ×1.1

372 ×0.9

PRM

212 ×0.6

RNMI

324 ×1.0

Citations per year, relative to Emanuela Ferraro Emanuela Ferraro (= 1×) peers Noam Pondé

Countries citing papers authored by Emanuela Ferraro

Since Specialization

Citations

This map shows the geographic impact of Emanuela Ferraro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Ferraro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Ferraro more than expected).

Fields of papers citing papers by Emanuela Ferraro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Ferraro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Ferraro. The network helps show where Emanuela Ferraro may publish in the future.

Co-authorship network of co-authors of Emanuela Ferraro

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Ferraro. A scholar is included among the top collaborators of Emanuela Ferraro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Ferraro. Emanuela Ferraro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nieddu, Francesco, Marina Vignoli, Emanuela Ferraro, et al.. (2025). Public health impact of nirsevimab and reduction of RSV hospitalisation in all infants: early real-world data from Tuscany (Italy) in the 2024–25 RSV season. European Journal of Pediatrics. 184(11). 728–728.

Lodi, Lorenzo, Maria Moriondo, Francesco Nieddu, et al.. (2025). Serotype 3 invasive pneumococcal disease in Tuscany across the eras of conjugate vaccines (2005–2024) and anthropic-driven respiratory virus fluctuations. Human Vaccines & Immunotherapeutics. 21(1). 2510005–2510005.

Ferraro, Emanuela, Pedram Razavi, Shanu Modi, et al.. (2025). Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan. JCO Precision Oncology. 9(9). e2400898–e2400898. 1 indexed citations

Ferraro, Emanuela, Anne S. Reiner, Umberto Tosi, et al.. (2025). Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease. JAMA Network Open. 8(1). e2457483–e2457483. 1 indexed citations

Ferraro, Emanuela, Andrea V. Barrio, Daniel J. Kelly, et al.. (2024). Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab. npj Breast Cancer. 10(1). 96–96.

Ferraro, Emanuela, Atif J. Khan, George Plitas, et al.. (2024). Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer. Cancer Research. 84(9_Supplement). PO3–4. 1 indexed citations

Moiso, Enrico, Emanuela Ferraro, Luc Cabel, et al.. (2024). Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2- metastatic breast cancer: A machine learning approach.. Journal of Clinical Oncology. 42(16_suppl). 1074–1074. 1 indexed citations

Ferraro, Emanuela, Anton Safonov, Yuan Chen, et al.. (2023). Abstract P4-02-01: Efficacy of HER2 ADCs against HER2 inhibitor resistance alterations in the PI3K and MAPK pathways in HER2-positive breast cancer. Cancer Research. 83(5_Supplement). P4–2. 2 indexed citations

Marra, Antonio, Dario Trapani, Emanuela Ferraro, & Giuseppe Curigliano. (2023). Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer. Cancer treatment and research. 188. 219–235. 7 indexed citations

10.

Ferraro, Emanuela & Andrew D. Seidman. (2023). Breast Cancer Brain Metastases: Achilles’ Heel in Breast Cancer Patients’ Care. Cancer treatment and research. 188. 283–302.

11.

Morganti, Stefania, Emanuela Ferraro, Liliana Ascione, et al.. (2022). Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls. Cancer Drug Resistance. 5. 971–80. 15 indexed citations

12.

Ferraro, Emanuela, Elaine M. Walsh, Jacqueline J. Tao, Sarat Chandarlapaty, & Komal Jhaveri. (2022). Accelerating drug development in breast cancer: New frontiers for ER inhibition. Cancer Treatment Reviews. 109. 102432–102432. 37 indexed citations

13.

Drago, Joshua Z., Emanuela Ferraro, Nour Abuhadra, & Shanu Modi. (2022). Beyond HER2: Targeting the ErbB receptor family in breast cancer. Cancer Treatment Reviews. 109. 102436–102436. 33 indexed citations

14.

Tarantino, Paolo, Erika Hamilton, Sara M. Tolaney, et al.. (2020). HER2-Low Breast Cancer: Pathological and Clinical Landscape. Journal of Clinical Oncology. 38(17). 1951–1962. 490 indexed citations breakdown →

15.

Nichetti, Federico, Antonio Marra, Carlo Alberto Giorgi, et al.. (2020). 337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study. Annals of Oncology. 31. S382–S382. 5 indexed citations

16.

Mazzarella, Luca, Bruno A. Duso, Dario Trapani, et al.. (2019). The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review. European Journal of Cancer. 117. 14–31. 80 indexed citations

17.

Belli, Carmen, Bruno A. Duso, Emanuela Ferraro, & Giuseppe Curigliano. (2019). Homologous recombination deficiency in triple negative breast cancer. The Breast. 45. 15–21. 59 indexed citations

18.

Tarantino, Paolo, Dario Trapani, Stefania Morganti, et al.. (2019). Opportunities and challenges of implementing Pharmacogenomics in cancer drug development. Cancer Drug Resistance. 2(1). 43–52. 2 indexed citations

19.

Morganti, Stefania, Paolo Tarantino, Emanuela Ferraro, et al.. (2018). Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life. Critical Reviews in Oncology/Hematology. 133. 171–182. 88 indexed citations

20.

Feng, Jianfeng, Emanuela Ferraro, & B. Tirozzi. (2005). Impact of temperature and pH value on the stability of hGHRH: An MD approach. Mathematical and Computer Modelling. 41(10). 1157–1170. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact